What’s Going On With Rivian Stock?

Rivian Automotive Inc (NASDAQ: RIVN) shares are trading lower by 3.37% to $15.47 Monday afternoon and lower by 35% in the month of October.

Rivian Automotive Inc (NASDAQ:RIVN) shares are trading lower by 3.37% to $15.47 Monday afternoon and lower by 35% in the month of October. The stock has experienced a recent decline amid weakness in the EV industry, influenced by Tesla Inc’s recent, disappointing third-quarter financial results, the rise in Treasury yields and by the pricing of $1.5 billion in green convertible senior notes offerings by Rivian.

See Also: What’s Going On With Tesla Stock?

Understanding Rivian’s October Weakness

Investor concerns have arisen over Rivian’s recent issuance of convertible senior notes, as it has increased the company’s debt burden. This elevated debt level could impede Rivian’s capacity to meet its financial commitments, potentially impacting its creditworthiness and resulting in higher interest expenses, potentially decreasing profitability.

See Also: What’s Going On With Intel Stock?

What Investors Should Know

Rivian is offering senior, unsecured notes with a 3.625% annual interest rate, making semi-annual payments from 2024 and maturing on October 15, 2030. They are convertible under specific conditions before July 15, 2030, or later at the discretion of noteholders.

The conversion offers cash, Rivian common stock, or a combination at an initial rate of 42.9290 shares per $1,000 note principal, equivalent to $23.29 per share, providing a 27.5% premium over the stock price on October 5.

The conversion rate may be adjusted due to certain events. The proceeds will be used for environmentally friendly projects in line with the Green Bond Principles of 2021.

According to data from Benzinga Pro, Rivian has a 52-week high of $36.45 and a 52-week low of $11.68.

Total
0
Shares
Related Posts
Read More

Reported Late Thursday April 13, Alvotech Provides Regulatory Update On AVT02 Biologics License Application; FDA Issued Complete Response Letter For Alvotech’s Biologics License Application For AVT02, A High-Concentration Biosimilar Candidate For Humir…

 Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug Administration (FDA) has

ALVO

Read More

Tilray Expands Weed Drink Selection, Here’s What RIFF Brand Has In Store For Cannaseurs

Canadian cannabis company Tilray has launched two new ready-to-drink THC and CBG-infused beverages as part of its RIFF brand. The RIFF BOOST drinks are available in Tropical Burst and Vanilla Frost flavours, and each contains 10mg of THC, 10mg of CBG and 30mg of naturally occurring caffeine from guarana extract. The beverages are available in 355ml cans. Tilray's RIFF brand debuted its first cannabis-infused beverages in July, with the introduction of sparkling THC drinks in Blue Raspberry Ice and Wild Raspberry Lemonade flavours. The new RIFF BOOST drinks are available in select regions and retailers in Canada, including Alberta, Manitoba and Ontario. Tilray expanded its cannabis beverage portfolio in November with products from its XMG and Mollo brands.

TLRY